Navigation Links
Stem cell research aims to tackle Parkinson's disease
Date:1/18/2008

Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinsons disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.

Professor Ernest Arenas of the Karolinska Institute in Stockholm presented his research to the EuroSTELLS Stem Cell Niches conference in Barcelona on January 11. Stem cell therapy hold the promise of treating disease by growing new tissues and organs from stem cells blank cells that have the potential to develop into fully mature or differentiated cells. The EuroSTELLS is an ESF EURCORES programme, managed by the European Medical Research Councils (EMRC), that aims to develop a stem cell toolbox by generating fundamental knowledge on stem cell biology.

Parkinsons disease affects around three in a hundred of people aged over 65. The condition can cause muscles to become rigid and limbs to tremble uncontrollably. Parkinsons disease results from the loss of a particular type of brain cell called dopaminergic (DA) neurons in the part of the brain called the substantia nigra.

Among the various approaches that are currently being discussed from an ethical perspective, is the possible approach of taking stem cells, growing them into new brain cells and transplanting these into the patient. The idea is to start with stem cells and induce them to become neurons, said Professor Arenas, whose research is carried out as part of a EuroSTELLS collaboration. These could then be transplanted into the brain of the patient. Also, such cells could be ideal for developing and testing new drugs to treat brain disease.

However, to create such cells that function efficiently and safely is a major challenge. Early efforts at growing DA neurons from embryonic stem cells produced cells which, when transplanted into animal models, had a tendency to form tumours or clumps, or die without an obvious reason.

Professor Arenass team studied the development of DA neurons in animals to determine the important biological molecules in the brain that were necessary for the cells to grow and function efficiently. The scientists identified one particular molecule that seemed to be key, a protein called Wnt5a. They showed that when this molecule, together with a second protein called noggin, was included in cultures of stem cells, far more DA neurons were produced than when these ingredients were not present.

The team then carried out a series of molecular, chemical and electrophysiological tests on the newly grown neurons to check their proficiency, which was shown to be good.

Crucially the team also moved away from embryonic stem cells which can be induced to grow into a wide variety of different cells. Instead they used neural stem cells which are programmed to develop only into nerve cells.

When the researchers transplanted the cells into laboratory animals whose substantia nigra region of the brain was damaged, the results were promising. We reversed almost completely the behavioural abnormalities, and neurons differentiated, survived and re-innervated the relevant part of the brain better Professor Arenas said. Furthermore we do not see the kind of proliferation of the cells that has occurred in the past and we get very little clustering when the cells are treated with Wnt5a. The cells are safer than embryonic stem cells and more efficient than fetal tissue.

Verification of this approach with human cells is ongoing and if the study is successful, it may lead to a clinical trial. Experts in the field have recently identified this approach as the next step in cell replacement therapy for Parkinsons disease and the hope is that this may, ultimately, lead to cells suitable for transplant into human patients.


'/>"/>

Contact: Dr. Fiona Kernan
fkernan@esf.org
33-388-762-180
European Science Foundation
Source:Eurekalert

Related biology news :

1. Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize
2. Researchers reveal HIV peptides possible pathway into the cell
3. Scientists call for urgent research into real impacts of invasive species
4. $13 million federal grant for research into vascular disease awarded to Weill Cornell
5. GM, Coskata partnership builds on Oklahoma State University biofuels research
6. USC researchers identify mechanism that controls activation of stem cells during hair regeneration
7. Researchers put the bite on mosquitoes
8. Montana State University researcher finds renewed interest in turning algae into fuel
9. Researchers find association between food insecurity and developmental risk in children
10. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
11. Japanese and German researchers meet to discuss climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
(Date:3/20/2017)... -- PMD Healthcare announces the release of its new ... (WMS), a remote, real-time lung health monitoring and management ... a Medical Device, Digital Health, and Chronic Care Management ... solutions that empower people to improve their healthcare and ... the first ever personal spirometer, Spiro PD, which was ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... MA (PRWEB) , ... March 23, 2017 , ... ... “a viscoelastic material that exhibits both viscous and elastic characteristics when deformed, which ... disc polymer exhibits properties to gently absorb compressive forces and return to its ...
(Date:3/23/2017)... LOUISVILLE, Colo. , March 23, 2017  GlobeImmune, ... purchase agreement for the sale of 12,835,490 shares of ... the  NantWorks  ecosystem of companies. In connection with the sale ... GlobeImmune $100,000 in cash and issue to GlobeImmune 200,000 ... common stock. "We are pleased to ...
(Date:3/23/2017)... March 23, 2017 According to a report ... derivatives market is fragmented due to the presence of a large pool ... Thermo Fisher , and Sigma-Aldrich, compete with each other in ... collectively, held more than 76% of this market in 2016.  ... As of now, a ...
(Date:3/22/2017)... ... 2017 , ... Researchers face a fundamental challenge as they ... tissues, bones, even whole organs to implant in people to treat disease or ... the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t fabricate ...
Breaking Biology Technology: